Skip to main content
Clinical Trials/NCT02528539
NCT02528539CompletedNot Applicable

Prevention of Secondary Lymphedema by Utilizing Self-management Education in Conjunction With Acupuncture Among Breast Cancer Patients Who Are at High Risk of Developing Lymphedema

Huntington Memorial Hospital2 sites in 1 country10 target enrollmentStarted: August 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Locations
2
Primary Endpoint
Arm circumference measurements of the upper limbs using at 4 cm interval

Study Overview

Brief Summary

Introduction: Breast cancer women who are treated with axillary node dissection are at increased risk for lymphedema - the lifetime risk in these women is estimated at 15-50% and the risk can significantly increase with chemotherapy and radiation therapy

Objectives:

  1. To evaluate the feasibility and effectiveness of implementing the integrative therapy program (ITP) intervention. ITP consists of self-management education in conjunction with acupuncture.
  2. To determine if ITP affects quality of life, self-efficacy, lymphedema knowledge, pain, and early detection and management of lymphedema.

Design: the exploratory study aims to evaluate the feasibility and benefits of the integrative therapy program (ITP) intervention post-operatively for 18 months.

Subjects: Women with breast cancer treated with axillary node dissection with normal baseline pre-operative bioimpedance (L-dex U400) score.

Sample size: 30 subjects

Detailed Description

Recruitment and Intervention:

The study participants are recruited by their breast surgeon after they undergo axillary node dissection surgery. 4-6 weeks following surgery, the participants will receive a combination of acupuncture and self management education .

Contents of self-management education include:

  1. Lymphedema knowledge: functions of the lymphatic system, anatomy of the lymph nodes and direction of the lymphatic drainage, risk factors that could precipitate lymphedema, the signs and symptoms of lymphedema and infection, and lymphedema resources.
  2. Selfcare techniques:healthy diet (eating whole food encouraged), neck, shoulder and chest wall stretching exercises, walk daily, self-manual lymphatic drainage with deep breathing techniques, and self-acupressure over eighteen months following their surgery.

Outcome measurements include: L-Dex U400 measurement, arm circumference, pain scale, self-efficacy, and lymphedema knowledge, and Functional Assessment of Cancer Therapy-Breast FACT-B.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects must be able to read and understand the informed consent form and have the capacity to give consent.
  • Adults age 18 and older
  • Subject with a newly diagnosed stage I-III breast cancer with a documented pre-operative baseline L-Dex U400 who underwent axillary lymph node dissection within 4-6 weeks prior to enrollment.
  • Subjects must be able to return to the study site for the duration of the study (18 months).

Exclusion Criteria

  • Subjects who do not read or understand the informed consent are ineligible.
  • Subjects who have any contraindications to the affected upper-limb exercises, which include congestive heart failure, cardiac arrhythmia, deep vein thrombosis, infectious disease complications such as cellulitis and lymphangitis.
  • Women with double mastectomy with axillary node dissection bilaterally.
  • Women with a prior history of axillary surgeries in the ipsilateral side and/or primary lymphedema
  • Women with metal implants (e.g. shoulder replacement) or cardiac implants (e.g. automated implanted cardiac defibrillator (AICD) or pacemaker).
  • All subjects with objective or subjective signs and symptoms of lymphedema.
  • Women of childbearing age who are pregnant.

Outcomes

Primary Outcomes

Arm circumference measurements of the upper limbs using at 4 cm interval

Time Frame: 18 months

measure the circumference in centimeters

Bioimpedance (L-dex U400)

Time Frame: 18 months

use L-dex machine

Secondary Outcomes

  • Quality of Life (Functional Assessment of Cancer Therapy-Breast)(18 months)
  • Self-Efficacy Scale(18 months)
  • Lymphedema Knowledge Scale(18 months)
  • Wong-Baker FACES Pain Scale(18 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Suzie Kline

PhD, NP, LAc

Huntington Memorial Hospital

Study Sites (2)

Loading locations...

Similar Trials